Followers | 609 |
Posts | 26741 |
Boards Moderated | 1 |
Alias Born | 08/12/2010 |
Thursday, April 11, 2024 12:34:29 PM
If there was ever a setup this, is it. Very low volume and PPS at depressed levels (vastly undervalued). I can point to other stocks with much higher (multiples) market caps with a fraction of the potential. All good for me and for the patient. I like getting in on bottoms. This is NOT a IHUB trading stock. This is a big money stock that will be moved by NON IHUB investors. If we haven't already been found with accumulation from weak retail selling, we soon will be imho.
As much as many would not like to hear this. When it is time, THEY WILL DECIDE when it leaves these levels. Honestly the more bashing and whining is a good sign.
Almost ALL of my biggest winners reacted this same way. Under the radar slow accumulation, folks trying to bash down a stock already beaten down to almost silliness levels with minimal volume.
Patience is key!
ALL POSTS are just my opinion! Never BUY/SELL stock based on only them! Perform your own DD and make your own decision!
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM